Clinical trials
Osteoarthritis, Knee trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 4 |
| 2016 | 7 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 2 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Terminated | 6 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Technische Universität Dresden | 6 |
| Aesculap AG | 4 |
| GlaxoSmithKline | 3 |
| Charite University, Berlin, Germany | 2 |
| Genzyme, a Sanofi Company | 2 |
| IBSA Institut Biochimique SA | 2 |
| Ludwig-Maximilians - University of Munich | 2 |
| Medivir | 2 |
| Menarini Group | 2 |
| Novartis | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis, Knee | 63 |
| Osteoarthritis | 16 |
| Pain | 9 |
| Osteoarthritis, Hip | 5 |
| Joint Diseases | 3 |
| Arthritis, Rheumatoid | 2 |
| Joint Instability | 2 |
| Musculoskeletal Diseases | 2 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.